SciELO - Scientific Electronic Library Online

 
vol.43 issue1Pulmonary and central nervous system nocardiosis: Alcoholism as an immunocompromising factorCalcium regulation by SERC-A before and during Alzheimer disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Biomédica

Print version ISSN 0120-4157On-line version ISSN 2590-7379

Abstract

VARGAS-POTES, Carlos Julio; MENDOZA-URBANO, Diana Marcela; PARRA-LARA, Luis Gabriel  and  R. ZAMBRANO, Ángela. Challenges in the care of Ewing’s sarcoma in a Jehovah’s Witness patient. Biomed. [online]. 2023, vol.43, n.1, pp.44-50.  Epub Mar 30, 2023. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.6720.

Ewing’s sarcoma is a bone and soft tissue neoplasm, whose management is related to hematological toxicity. This aspect represents a medical and ethical challenge in Jehovah’s Witnesses patients, who, due to their religious beliefs, reject the blood component transfusion, with the risk of discontinuing chemotherapy or using suboptimal doses.

We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T Jehová han criticado esta prácticN0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.

Keywords : sarcoma, Ewing; drug therapy; anemia; blood component transfusion.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )